Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases
QurAlis Raises $5.5 Million Seed Round - Wins Pfizer Sponsored Golden Ticket to LabCentral
Biotech ALS-focused QurAlis raises $5.5M in seed money, wins Pfizer ticket to LabCentral
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
Astellas Pharma : buys Potenza Therapeutics for up to $405m
The 2019 30-under-30 getting personal to fix the system
Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders
Affinivax, Inc. announces initiation of Phase 1/2 clinical study of ASP3772, its novel pneumococcal MAPS vaccine, in collaboration with Astellas
Torque and Thermo Fisher Scientific Announce Collaboration to Build State-of-the-Art Facility to Manufacture Torque’s Deep-Primed T Cell Immunotherapies
Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors, Opening Potential for CAR-T and Other Cellular Medicines in New Settings
